27
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Reversibility of experimental cholesteatoma epithelium using Mongolian gerbils

, , , &
Pages 540-546 | Received 23 Aug 2004, Accepted 22 Dec 2004, Published online: 19 Jul 2011

References

  • Shinoda H, Huang CC. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and pro-grammed cell death. Laryngoscope 1995;105:1232–7.
  • Holly A, Sittinger M, Bujia J. Immunohistochemical de-monstration of c-myc oncogene product in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1995;252:366–9.
  • Albino AP, Reed JA, Bogdany JK, Sassoon J, Desloge RB, Parisier SC. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications. Am J Otol 1998; 19:30–6.
  • McGinn MD, Chole RA, Henry KR. Cholesteatoma: experimental induction in the Mongolian Gerbil, Meriones Unguiculaus. Acta Otolaryngol (Stockh) 1982;93:61–7.
  • Chole RA, Henry KR, McGinn MD. Cholesteatoma: spontaneous occurrence in the Mongolian gerbil, meriones unguiculatis. Am J Otol 1981;2:204–10.
  • Albino AP, Kimmelman CP, Parisier SC. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998;19:7–19.
  • Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, Haake AR. Apoptosis in human skin development: morpho-genesis, periderm, and stem cells. Dev Dyn 1994;199:176–88.
  • Weedon D, Searle J, Kerr JF. Apoptosis: its nature and implications for dermatopathology. Am J Dermatopathol 1979;1:133–44.
  • Kojima H, Tanaka Y, Tanaka T, Miyazaki H, Shiwa M, Kamide Y, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1998;124:261–4.
  • Park HJ, Park K. Expression of Fas/APO-1 and apoptosis of keratinocytes in human cholesteatoma. Laryngoscope 1999; 109:613–6.
  • Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493–501.
  • Bujia J, Schilling V, Holly A, Stammberger M, Kastenbauer E. Hyperproliferafion-associated keratin expression in hu-man middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1993;113:364–8.
  • Sasaki H, Huang CC. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma. Otolaryngol Head Neck Surg 1994;110:310–7.
  • Park K, Park HJ, Chun YM. Immunohistochemical study of cytokeratin expression in experimental cholesteatoma. In: Lim DJ, Bluestone CD, Casselbrant M, Klein JO, Ogra PL, editors. Recent Advances in Otitis Media—Proceedings of the Sixth International Symposium. Hamilton, Ont.: B.C. Decker Inc; 1996. p. 275–7.
  • Kim HJ, Tinling SP, Chole RA. Expression patterns of cytokeratins in retraction pocket cholesteatomas. Laryngo-scope 2001;111:1032–6.
  • Uchida N, Ito S, Hirano M. Localization of proliferating cell nuclear antigen in aural cholesteatoma. Kurume Med J 1993;40:225–8.
  • Bujia J, Sudhoff H, Holly A, Hildmann H, Kastenbauer E. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolar-yngol 1996;253:21–4.
  • Park K, Chun YM. Immunohistochemical detection of proliferating cell nuclear antigen in experimental cholestea-toma. In: Takasaka T, editor. Proceedings of Sendai Ear Symposium. Sendai, Japan: Sasaki Printing & Publishing Co; 1996. p. 125–7.
  • Park K, Park HJ, Chun YM. Immunohistochemical study on proliferative activity of experimental cholesteatoma. Eur Arch Otorhinolaryngol 2001;258:101–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.